Logo for Adocia SA

Adocia Investor Relations Material

Latest events

Logo for Adocia

H1 2024

19 Sep, 2024
Logo for Adocia

Q2 2024 TU

24 Jul, 2024
Access the full event backlog
Slides, Transcripts, and Reports from 9,000+ public companies

Latest reports from Adocia SA

Access all reports
Adocia SA is a biotechnology company focused on the development of innovative therapies for the treatment of diabetes and other metabolic diseases. The company specializes in creating advanced formulations of already approved therapeutic proteins, aiming to improve their efficacy and patient experience. Adocia's technology platforms are designed to optimize the delivery and performance of these treatments, particularly in the field of insulin therapy. The company is headquartered in Lyon, France, and its shares are listed on the Euronext Paris exchange.